Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
26.09
+1.32 (5.33%)
At close: Sep 22, 2026, 4:00 PM EDT
26.09
0.00 (0.00%)
After-hours: Sep 22, 2026, 4:54 PM EDT
KMTS Revenue
Kestra Medical Technologies had revenue of $30.97M in the quarter ending July 31, 2026, with 59.88% growth. This brings the company's revenue in the last twelve months to $106.73M, up 60.72% year-over-year. In the fiscal year ending April 30, 2026, Kestra Medical Technologies had annual revenue of $95.13M with 59.03% growth.
Revenue (ttm)
$106.73M
Revenue Growth
+60.72%
P/S Ratio
14.56
Revenue / Employee
$240,916
Employees
443
Market Cap
1.55B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2026 | 95.13M | 35.31M | 59.03% |
| Apr 30, 2025 | 59.82M | 32.00M | 115.05% |
| Apr 30, 2024 | 27.81M | 20.18M | 264.53% |
| Apr 30, 2023 | 7.63M | - | - |
| Apr 30, 2021 | - | - | - |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.64B |
| Envista Holdings | 2.86B |
| ICU Medical | 2.16B |
| Warby Parker | 911.61M |
| Azenta | 613.81M |
| AtriCure | 569.62M |
| STAAR Surgical Company | 339.59M |
| AngioDynamics | 320.17M |
KMTS News
- 8 days ago - Kestra Medical down 7% at $22.32 after Q1 earnings miss - TheFly
- 8 days ago - Kestra Medical Technologies Earnings Call Transcript: Q1 2027 - Transcripts
- 8 days ago - Kestra Medical Technologies Earnings release: Q1 2027 - Filings
- 8 days ago - Kestra Medical Technologies Quarterly report: Q1 2027 - Filings
- 8 days ago - Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results - GlobeNewsWire
- 11 days ago - Kestra Medical Technologies Slides: Corporate presentation - Filings
- 12 days ago - Kestra Names Daniel Finney Vice President of Research & Development - GlobeNewsWire
- 13 days ago - Kestra Medical Technologies Transcript: AGM 2026 - Transcripts